Effects of intracellular free cholesterol accumulation on macrophage viability: a model for foam cell death.

This study was designed to identify cellular responses associated with free cholesterol (FC) accumulation in model macrophage foam cells. Mouse peritoneal macrophages (MPMs) or J774 macrophages were loaded with cholesteryl esters using acetylated LDL and FC/phospholipid dispersions and were subsequently exposed to an acyl coenzyme A:cholesterol acyltransferase (ACAT) inhibitor. This treatment produced a rapid accumulation of cellular FC. The FC that accumulated due to ACAT inhibition was more readily available for efflux to 2-hydroxypropyl-beta-cyclodextrin (which removes cholesterol from the plasma membrane) than FC in untreated control cells. After a 3-hour exposure to an ACAT inhibitor, a significant increase in phospholipid synthesis was seen, followed by the leakage of LDH after 12 hours of treatment. We also observed, by electron and fluorescence microscopy, morphological indications of both apoptosis and necrosis in cells treated with an ACAT inhibitor. In addition, inhibition of ACAT for 48 hours resulted in the formation of FC crystals in MPMs but not in J774 cells. If compound 3beta-[2-(diethylamino)ethoxy]androst-5-en-17-one (U18666A), which modulates intracellular trafficking of cholesterol, was added together with the ACAT inhibitor, each of the metabolic changes elicited by the accumulation of excess FC was either diminished or eliminated. The protective affect of U18666A was not due to a decrease in cellular FC concentrations, because cells treated with an ACAT inhibitor accumulated similar amounts of FC in the presence or absence of U18666A. Thus, treatment with U18666A results in the sequestering of FC in a pool that prevents it from causing various responses to FC deposition in macrophages. The metabolic changes that were produced when these model foam cells were treated with the ACAT inhibitor parallel the pathological events that have been shown to occur in the developing atherosclerotic plaque.

[1]  M C Phillips,et al.  Use of cyclodextrins for manipulating cellular cholesterol content. , 1997, Journal of lipid research.

[2]  M J Davies,et al.  Relation of plaque lipid composition and morphology to the stability of human aortic plaques. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[3]  J. Thyberg,et al.  Cell death in human atherosclerotic plaques involves both oncosis and apoptosis. , 1997, Atherosclerosis.

[4]  Richard T. Lee,et al.  Macrophages and atherosclerotic plaque stability , 1996, Current opinion in lipidology.

[5]  I. Tabas,et al.  Evidence That the Initial Up-regulation of Phosphatidylcholine Biosynthesis in Free Cholesterol-loaded Macrophages Is an Adaptive Response That Prevents Cholesterol-induced Cellular Necrosis , 1996, The Journal of Biological Chemistry.

[6]  B. Björkerud,et al.  Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. , 1996, The American journal of pathology.

[7]  W. J. Johnson,et al.  Cellular Cholesterol Efflux Mediated by Cyclodextrins , 1996, The Journal of Biological Chemistry.

[8]  I. Weissman,et al.  Activation of physiological cell death mechanisms by a necrosis‐causing agent , 1996, Microscopy research and technique.

[9]  A. Tall,et al.  Interleukin 8 Is Induced by Cholesterol Loading of Macrophages and Expressed by Macrophage Foam Cells in Human Atheroma (*) , 1996, The Journal of Biological Chemistry.

[10]  E. Falk,et al.  Vulnerable and dangerous coronary plaques. , 1995, Atherosclerosis.

[11]  L. Liscum,et al.  Intracellular Cholesterol Transport and Compartmentation (*) , 1995, The Journal of Biological Chemistry.

[12]  N. Ridgway.  Inhibition of acyl-CoA:cholesterol acyltransferase in Chinese hamster ovary (CHO) cells by short-chain ceramide and dihydroceramide. , 1995, Biochimica et biophysica acta.

[13]  J. Skepper,et al.  Evidence that the death of macrophage foam cells contributes to the lipid core of atheroma. , 1995, Atherosclerosis.

[14]  W. J. Johnson,et al.  Cell Toxicity Induced by Inhibition of Acyl Coenzyme A:Cholesterol Acyltransferase and Accumulation of Unesterified Cholesterol * , 1995, The Journal of Biological Chemistry.

[15]  D. Harrison,et al.  Cell death in health and disease: the biology and regulation of apoptosis. , 1995, Seminars in cancer biology.

[16]  E Farber,et al.  Programmed cell death: necrosis versus apoptosis. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[17]  I. Tabas,et al.  Free cholesterol loading of macrophages stimulates phosphatidylcholine biosynthesis and up-regulation of CTP: phosphocholine cytidylyltransferase. , 1994, The Journal of biological chemistry.

[18]  R. Tangirala,et al.  Lysosomal accumulation of unesterified cholesterol in model macrophage foam cells. , 1993, The Journal of biological chemistry.

[19]  J. Guyton,et al.  Early extracellular and cellular lipid deposits in aorta of cholesterol-fed rabbits. , 1992, The American journal of pathology.

[20]  G. Rothblat,et al.  Cellular cholesterol efflux. Role of cell membrane kinetic pools and interaction with apolipoproteins AI, AII, and Cs. , 1992, The Journal of biological chemistry.

[21]  M. Phillips,et al.  Cholesterol efflux from arterial wall cells , 1991 .

[22]  Gwyn T. Williams,et al.  Activation of Epstein–Barr virus latent genes protects human B cells from death by apoptosis , 1991, Nature.

[23]  G. Rothblat,et al.  cAMP stimulates cholesteryl ester clearance to high density lipoproteins in J7774 macrophages. , 1991, The Journal of biological chemistry.

[24]  J. Clader,et al.  Rabbit and human liver contain a novel pentacyclic triterpene ester with acyl-CoA: cholesterol acyltransferase inhibitory activity. , 1990, The Journal of biological chemistry.

[25]  D. Small,et al.  George Lyman Duff memorial lecture. Progression and regression of atherosclerotic lesions. Insights from lipid physical biochemistry. , 1988, Arteriosclerosis.

[26]  N. Simionescu,et al.  Development of intracellular lipid deposits in the lipid-laden cells of atherosclerotic lesions. A cytochemical and ultrastructural study. , 1987, Atherosclerosis.

[27]  G. Rothblat,et al.  Cholesteryl ester cycle in cultured hepatoma cells. , 1987, Atherosclerosis.

[28]  Richard G. Taylor,et al.  Foam Cell Characteristics in Coronary Arteries and Aortas of White Carneau Pigeons with Moderate Hypercholesterolemia a , 1985, Annals of the New York Academy of Sciences.

[29]  R. G. Anderson,et al.  Morphological characterization of the cholesteryl ester cycle in cultured mouse macrophage foam cells , 1983, The Journal of cell biology.

[30]  M. Phillips,et al.  The stability and structure of cholesterol-rich codispersions of cholesterol and phosphatidylcholine. , 1982, Journal of lipid research.

[31]  D. Small,et al.  Isolation and and partial characterization of the lipid phases of human atherosclerotic plaques. , 1980, Journal of Biological Chemistry.

[32]  M. Brown,et al.  The cholesteryl ester cycle in macrophage foam cells. Continual hydrolysis and re-esterification of cytoplasmic cholesteryl esters. , 1980, The Journal of biological chemistry.

[33]  M. Brown,et al.  Hydrolysis and excretion of cytoplasmic cholesteryl esters by macrophages: stimulation by high density lipoprotein and other agents. , 1980, Journal of lipid research.

[34]  G. Shipley,et al.  The phase behavior of hydrated cholesterol. , 1979, Journal of lipid research.

[35]  N. Tolbert,et al.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. , 1978, Analytical biochemistry.

[36]  L. Arbogast,et al.  Cellular cholesterol ester accumulation induced by free cholesterol-rich lipid dispersions. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Brown,et al.  Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[38]  G. Shipley,et al.  Physical chemistry of the lipids of human atherosclerotic lesions. Demonstration of a lesion intermediate between fatty streaks and advanced plaques. , 1976, The Journal of clinical investigation.

[39]  H. Lofland,et al.  Influence of atherosclerosis on the composition, synthesis, and esterification of lipids in aortas of squirrel monkeys (Saimiri sciureus). , 1969, Journal of atherosclerosis research.

[40]  R. Morin.  Phospholipid composition and synthesis in male rabbit aortas. , 1968, Metabolism: clinical and experimental.

[41]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[42]  R. Oppenheim,et al.  Neuron death in vertebrate development: in vitro methods. , 1995, Methods in cell biology.

[43]  J. Kerr,et al.  Anatomical methods in cell death. , 1995, Methods in cell biology.

[44]  G. Majno,et al.  Apoptosis, oncosis, and necrosis. An overview of cell death. , 1995, The American journal of pathology.

[45]  R. Oppenheim,et al.  Chapter 13 Neuron Death in Vertebrate Development: In Vivo Methods , 1995 .

[46]  W. J. Johnson,et al.  Formation of cholesterol monohydrate crystals in macrophage-derived foam cells. , 1994, Journal of lipid research.

[47]  B. Storrie,et al.  Isolation of subcellular organelles. , 1990, Methods in enzymology.

[48]  J. Guyton,et al.  Extracellular lipid deposition in atherosclerosis. , 1990, European heart journal.

[49]  H. C. Stary,et al.  The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life. , 1990, European heart journal.

[50]  G. Rothblat,et al.  Influence of high density lipoprotein on esterified cholesterol stores in macrophages and hepatoma cells. , 1990, Arteriosclerosis.

[51]  F. Soubrier,et al.  Clinical implications of the molecular biology of the renin-angiotensin system. , 1990, European heart journal.

[52]  A. Gown,et al.  Fatty streak expansion and maturation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. , 1987, Arteriosclerosis.

[53]  M. Brown,et al.  Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. , 1983, Annual review of biochemistry.

[54]  M. Brown,et al.  The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages. , 1980, Journal of supramolecular structure.

[55]  A. Wyllie,et al.  Cell death: the significance of apoptosis. , 1980, International review of cytology.

[56]  R. Wissler,et al.  Progression and regression of atherosclerotic lesions. , 1978, Advances in experimental medicine and biology.

[57]  F. Hatch.  Practical methods for plasma lipoprotein analysis. , 1968, Advances in lipid research.

[58]  O. Portman,et al.  Nutritional control of arterial lipid composition in squirrel monkeys: major ester classes and types of phospholipids. , 1967, The Journal of nutrition.